Dr. Carolyn Anderson’s new R01, “PET Probes Targeting Immune Cells for Imaging Tuberculosis” was recently recommended for funding. This study will develop new PET imaging probes that target activated macrophages and neutrophils found in TB lesions, which could eventually lead to more accurate diagnoses and techniques to assess treatment response.
The Department of Defense’s Peer Reviewed Medical Research Program has recommended funding for a clinical trial led by Dr. Ty Bae. This multi-site trial will evaluate the generic diabetes drug metformin as a novel therapy for autosomal dominant polycystic kidney disease, a common inherited kidney disease for which there is no cure.